Christopher EllisCEO Dynamic Physio Therapy

Why Insulin Should Be on Every Blood Panel

17 Oct 2026 · 1 min

Watch on YouTube

0:45

In this brief monologue, Christopher Ellis argues that insulin measurement should be a standard component of routine blood panels. He points out that many individuals who are progressing toward diabetes are told their glucose and A1C levels are normal, because glucose is a volatile marker and A1C can appear acceptable even while insulin is already rising. Ellis explains that insulin is typically the first biomarker to increase, signaling the onset of pre‑diabetes before blood sugar abnormalities become evident. He further links elevated insulin to the underlying mechanisms of many chronic diseases, asserting that routinely measuring insulin would allow clinicians to intervene earlier and make healthcare more proactive.

Chapters

I don't know why insulin is not on every panel. That should be automatic. The amount of people I catch that are becoming diabetic or pre-diabetic, they're told their sugars are fine, their glucose looks normal. Glucose is a very finicky marker, first of all. Um, A1C can look good but maybe trending in the wrong way. Um, it's the first shoe to drop usually is insulin. So in other words, insulin will keep elevating and your A1C can still look good, but once that insulin starts elevating too much, then you're going into pre-diabetic territory. So And blood sugar issues are probably the, you know, the backbone of so many chronic diseases. So that if we just did that one thing, I feel like we would be so much more proactive in healthcare.